Yasumichi Hitoshi is the founder of Thyas Co. Ltd.. Latest round: Series B. Backed by D3 LLC, Eight Roads Ventures, F-Prime Capital. Based in Kyoto, Japan.
Yasumichi Hitoshi is the President of Thyas Inc., which changed its name to Sinobi Therapeutics Inc. in December 2023. He joined the company as president in June 2017 after his interest in immunology and cancer treatment led him to pursue the company's mission to cure cancer with immune cells.
Full founder directory · Investor directory · Company funding database · Fundraising library